We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EVAX market cap is 17.69M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 73k | 51k | 154k | 3.02M | 122k |
| Operating Income | -4.36M | -4.4M | -4.58M | -1.73M | -4.02M |
| Net Income | -4.52M | 1.19M | -6.2M | -1.93M | -3.63M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 73k | 3.34M |
| Operating Income | -16.57M | -25.83M | -25.26M | -22.2M | -14.73M |
| Net Income | -15.02M | -24.53M | -23.17M | -22.13M | -10.57M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.89M | 22.65M | 15.23M | 15.19M | 12.49M |
| Total Liabilities | 17.62M | 20.05M | 13.98M | 15.11M | 14.14M |
| Total Equity | -4.73M | 2.6M | 1.25M | 74k | -1.65M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.97M | 40.16M | 22.03M | 12.89M | 12.49M |
| Total Liabilities | 4.93M | 7.73M | 13.72M | 17.62M | 14.14M |
| Total Equity | 7.04M | 32.44M | 8.3M | -4.73M | -1.65M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.69M | N/A | -8.99M | N/A | -12.94M |
| Investing | -93k | N/A | -3k | N/A | -3k |
| Financing | 10.69M | N/A | 11.39M | N/A | 13.13M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.44M | -21.93M | -25.77M | -17.69M | -12.94M |
| Investing | -393k | -1.33M | -268k | -93k | -3k |
| Financing | 8.82M | 49.81M | 7.85M | 10.69M | 13.13M |
| Market Cap | 17.69M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 6.32M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.21 (7%) |
| Company Name | Evaxion AS |
| Address |
dr. neergaards vej 5f horsholm 2970 |
| Website | https://www.evaxion-biotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
